Cutis marmorata telangiectatica congenita, abbreviated CMTC, is a rare congenital vascular disorder that usually affects the blood vessels of the skin. It was first recognised and described in 1922 by Cato van Lohuizen, a Dutch pediatrician, and the condition is therefore also called Van Lohuizen syndrome. The same name is used as a synonym for congenital generalized phlebectasia, nevus vascularis reticularis, congenital phlebectasia, livedo telangiectatica and congenital livedo reticularis. It should not be confused with the general term cutis marmorata, which refers to livedo reticularis caused by cold. This entry is a reference record and not medical advice.
Facts
Classification
ICD-10 ChapterXVII: Congenital Malformations, Deformations and Chromosomal Abnormalities 2 First Described Prevalence Band Sources
1. Cutis marmorata telangiectatica congenita (Wikipedia)
Lead section
first recognized and described in 1922 by Cato van Lohuizen
Lead section [body-system]
affecting the blood vessels of the skin
Lead section [body-system 2]
a rare congenital vascular disorder
View the Source2. Orphadata (Orphanet): Orphadata cross-references, ORPHAcode 1556
Orphadata (Orphanet)Orphanet cross-reference to ICD-10, chapter derived from the codeQuote, Orphanet cross-reference to ICD-10, chapter derived from the code
"Reference": "Q82.8", "Source": "ICD-10"
View the Source 3. Orphadata (Orphanet): Orphadata epidemiology, ORPHAcode 1556
Orphadata (Orphanet)Orphanet epidemiology, ORPHAcode 1556Quote, Orphanet epidemiology, ORPHAcode 1556
"PrevalenceClass": "\u003c1 / 1 000 000", "PrevalenceGeographic": "Worldwide", "PrevalenceQualification": "Class only", "PrevalenceType": "Point prevalence"
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.